| ||
| Synta Announces Encouraging Preliminary Results for Ganetespib ... Synta Announces Encouraging Preliminary Results for Ganetespib (STA-9090) in Phase 2 Non-small Cell Lung Cancer Trial. Feb 26, 2011 11:35:00 AM ... finance.alphatrade.com/.../201102261135BIZWIRE_USPR__... | ||
| Synta to initiate Phase IIb/III lung cancer trial (Pathology ... Synta Announces Phase 2b/3 Trial for Ganetespib (STA-9090) in Advanced 2nd-line Non-small Cell Lung Cancer. Company news; 2 days ago; by Business Wire ... news.reportlinker.com/.../Synta-to-initiate-Phase-IIb-III-lung-c... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment